29 results on '"Dalton, William S."'
Search Results
2. Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC
3. BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models
4. Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity
5. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
6. Sequence of novel agents in multiple myeloma: An instrumental variable analysis
7. Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
8. Monitoring a Nuclear Factor-κB Signature of Drug Resistance in Multiple Myeloma
9. Kinome Sirna Screen Identifies SMG-1 as a Negative Regulator of Hypoxia-inducible Factor-1α in Hypoxia
10. Static adhesion of cancer cells to glass surfaces coated with glycosaminoglycans
11. Proteomic Contributions to Personalized Cancer Care
12. A Protective Role for the Human SMG-1 Kinase against Tumor Necrosis Factor-α-induced Apoptosis
13. Tumor microenvironment and drug resistance in hematologic malignancies
14. The cytoplasmic trafficking of DNA topoisomerase IIα correlates with etoposide resistance in human myeloma cells
15. Targeting the bone marrow microenvironment in hematologic malignancies
16. Drug resistance and drug development in multiple myeloma
17. The tumor microenvironment as a determinant of drug response and resistance
18. pH and drug resistance. I. functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines
19. Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
20. Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines
21. ALTERNATIVE (NON–P-GLYCOPROTEIN) MECHANISMS OF DRUG RESISTANCE IN NON-HODGKIN'S LYMPHOMA
22. Decreased CP-1 (NF-Y) Activity Results in Transcriptional Down-Regulation of Topoisomerase IIα in a Doxorubicin-Resistant Variant of Human Multiple Myeloma RPMI 8226
23. Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells
24. Drug Resistance in Myeloma: Mechanisms and Approaches to Circumvention
25. Modification of keratin by the chemotherapeutic drug mitoxantrone
26. Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cells
27. Isolated local-regional failure after mastectomy and adriamycin-cytoxan chemotherapy: A role for postoperative radiotherapy in breast cancer
28. Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line
29. Mitomycin C resistant L1210 leukemia cells: Association with pleiotropic drug resistance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.